L-arginine in combination with sildenafil potentiates the attenuation of hypoxic pulmonary hypertension in rats

• Published in: Physiological research Vol. 62; no. 6; pp. 589 - 595
• Main Authors: Al-Hiti, H, Chovanec, M, Melenovský, V, Vajnerová, O, Baňasová, A, Kautzner, J, Herget, J
• Format: Journal Article
• Language: English
• Published: Czech Republic Institute of Physiology 01-01-2013
• Subjects: Animals; Arginine - administration & dosage; Blood Pressure - drug effects; Drug Synergism; Drug Therapy, Combination; Hypertension, Pulmonary - drug therapy; Hypertension, Pulmonary - etiology; Hypertension, Pulmonary - physiopathology; Hypoxia - complications; Hypoxia - drug therapy; Hypoxia - physiopathology; Male; Muscular system; Nitric oxide; Piperazines - administration & dosage; Pulmonary Gas Exchange - drug effects; Purines - administration & dosage; Rats; Rats, Wistar; Rodents; Sildenafil Citrate; Studies; Sulfones - administration & dosage; Treatment Outcome; Vasodilator Agents - administration & dosage
• ISSN: 0862-8408; 1802-9973
• DOI: 10.33549/physiolres.932463

Chronic hypoxia induces an increased production of nitric oxide (NO) in pulmonary prealveolar arterioles. Bioavailability of the NO in the pulmonary vessels correlates with concentration of L-arginine as well as activity of phosphodiesterase-5 enzyme (PDE-5). We tested a hypothesis whether a combination of L-arginine and PDE-5 inhibitor sildenafil has an additive effect in reduction of the hypoxic pulmonary hypertension (HPH) in rats. Animals were exposed to chronic normobaric hypoxia for 3 weeks. In the AH group, rats were administered L-arginine during chronic hypoxic exposure. In the SH group, rats were administered sildenafil during chronic hypoxic exposure. In the SAH group, rats were treated by the combination of L-arginine as well as sildenafil during exposure to chronic hypoxia. Mean PAP, structural remodeling of peripheral pulmonary arterioles (%DL) and RV/LV+S ratio was significantly decreased in the SAH group compared to hypoxic controls even decreased compared to the AH and the SH groups in first two measured parameters. Plasmatic concentration of cGMP and NOx were significantly lower in the SAH group compared to hypoxic controls. We demonstrate that NO synthase substrate L-arginine and phosphodiesterase-5 inhibitor sildenafil administered in combination are more potent in attenuation of the HPH compared to a treatment by substances given alone.